e-Drug3D

1713

cas 174671-46-6

CLASS

ANTIINFECTIVES
OXABOROLE ANTIFUNGAL

ROUTE (list)

TOPICAL

PK parameters

MW 151.93
NB_atoms 11
XLogP 0.04
PSA 32.623
NB_HD 1
NB_HA 2
fsp3 0.14
Lipinski(0=no;1=yes) 1

FDA
NDA 204427 (label) INN (TAVABOROLE) KERYDIN (ANACOR PHARMS INC) APPROVAL= AP YEAR= 2014 NEWMOLECULARENTITY DISCONTINUED
NDA 211297 (pdf not found) INN (TAVABOROLE) TAVABOROLE (ENCUBE) APPROVAL= AP YEAR= 2020
NDA 211848 (pdf not found) INN (TAVABOROLE) TAVABOROLE (PADAGIS US) APPROVAL= AP YEAR= 2020
NDA 212188 (pdf not found) INN (TAVABOROLE) TAVABOROLE (ALEMBIC) APPROVAL= AP YEAR= 2020
NDA 212256 (pdf not found) INN (TAVABOROLE) TAVABOROLE (AMNEAL) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 212215 (pdf not found) INN (TAVABOROLE) TAVABOROLE (TARO) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 211963 (pdf not found) INN (TAVABOROLE) TAVABOROLE (CHARTWELL RX) APPROVAL= AP YEAR= 2021
NDA 212168 (pdf not found) INN (TAVABOROLE) TAVABOROLE (LUPIN LTD) APPROVAL= AP YEAR= 2021
NDA 212224 (pdf not found) INN (TAVABOROLE) TAVABOROLE (CIPLA) APPROVAL= AP YEAR= 2021
NDA 212294 (pdf not found) INN (TAVABOROLE) TAVABOROLE (ZYDUS LIFESCIENCES) APPROVAL= AP YEAR= 2023